Private Trust Co. NA decreased its holdings in shares of Humana Inc. (NYSE:HUM – Free Report) by 5.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 668 shares of the insurance provider’s stock after selling 38 shares during the period. Private Trust Co. NA’s holdings in Humana were worth $212,000 as of its most recent SEC filing.
Other hedge funds have also recently made changes to their positions in the company. Swedbank AB acquired a new position in Humana during the 1st quarter valued at about $37,174,000. Atria Investments Inc lifted its holdings in shares of Humana by 14.5% in the first quarter. Atria Investments Inc now owns 5,329 shares of the insurance provider’s stock valued at $1,848,000 after purchasing an additional 673 shares in the last quarter. Cetera Investment Advisers lifted its holdings in shares of Humana by 249.0% in the first quarter. Cetera Investment Advisers now owns 20,945 shares of the insurance provider’s stock valued at $7,262,000 after purchasing an additional 14,944 shares in the last quarter. Cetera Advisors LLC grew its holdings in Humana by 472.1% during the first quarter. Cetera Advisors LLC now owns 10,098 shares of the insurance provider’s stock worth $3,501,000 after buying an additional 8,333 shares in the last quarter. Finally, Clear Rock Advisors LLC boosted its holdings in Humana by 4.0% during the 1st quarter. Clear Rock Advisors LLC now owns 5,131 shares of the insurance provider’s stock worth $1,779,000 after acquiring an additional 199 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research analysts recently weighed in on HUM shares. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a research report on Thursday, October 3rd. Royal Bank of Canada reduced their target price on Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Jefferies Financial Group downgraded Humana from a “buy” rating to a “hold” rating and reduced their price objective for the company from $519.00 to $253.00 in a research note on Monday, October 7th. Oppenheimer cut their price target on shares of Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a report on Thursday, October 3rd. Finally, Wells Fargo & Company decreased their price objective on shares of Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a report on Monday, November 4th. Twenty research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Humana currently has an average rating of “Hold” and an average price target of $315.86.
Humana Stock Up 0.4 %
Shares of NYSE HUM opened at $296.68 on Friday. The business has a 50-day simple moving average of $275.60 and a two-hundred day simple moving average of $329.77. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $526.47. The company has a market cap of $35.72 billion, a P/E ratio of 26.28, a P/E/G ratio of 2.40 and a beta of 0.52. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67.
Humana (NYSE:HUM – Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The company had revenue of $29.30 billion during the quarter, compared to analysts’ expectations of $28.66 billion. Research analysts anticipate that Humana Inc. will post 15.86 earnings per share for the current fiscal year.
Humana Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.19%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s payout ratio is 31.36%.
Humana Company Profile
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Recommended Stories
- Five stocks we like better than Humana
- Following Congress Stock Trades
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How to buy stock: A step-by-step guide for beginners
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Canadian Penny Stocks: Can They Make You Rich?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.